Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France

We analyzed demographic characteristics, comorbidities and patterns of treatment with tyrosine kinase inhibitors (TKIs) in a cohort of 3,633 incident cases of chronic myeloid leukemia (CML) identified across France from 1 January 2011 to 31 December 2014. Patients were identified through a specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Pajiep, Marie, Conte, Cécile, Huguet, Françoise, Gauthier, Martin, Despas, Fabien, Lapeyre-Mestre, Maryse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515137/
https://www.ncbi.nlm.nih.gov/pubmed/34660261
http://dx.doi.org/10.3389/fonc.2021.675609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515137/
https://www.ncbi.nlm.nih.gov/pubmed/34660261
http://dx.doi.org/10.3389/fonc.2021.675609

Ejemplares similares